SCHEDULE: Deerfield Management Reduces Stake in Inspire Medical

Deerfield Management and James E. Flynn have filed an amendment to their Schedule 13G, disclosing that their beneficial ownership in Inspire Medical Systems, Inc. has fallen below the 5% threshold.

Summary

• Deerfield Management and associated entities reported a reduction in their beneficial ownership of Inspire Medical Systems, Inc. common stock.
• As of May 14, 2026, the reporting persons beneficially own 1,296,862 shares, representing 4.50% of the outstanding class.
• This filing serves as an amendment to previous disclosures, confirming the group no longer holds a greater than 5% stake in the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure reflecting standard portfolio rebalancing rather than a fundamental change in the company's business health.

Positives

• The reduction in stake indicates a strategic portfolio adjustment by a major institutional investor.

Negatives

• The exit of a significant institutional holder from the 5% ownership threshold may be perceived as a lack of long-term conviction by some market participants.

Risks

• Potential downward pressure on share price due to the divestment of a large block of shares by an institutional investor.

Future Outlook

No specific future outlook or guidance regarding the issuer's operations was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that institutional divestment filings like this are common in the medical device sector as funds rebalance portfolios, though they often trigger short-term volatility in the issuer's stock price.

Comparison to Industry Standards

• The filing follows standard SEC disclosure requirements for institutional investors dropping below the 5% reporting threshold.
• The reporting group's activity is consistent with typical portfolio management practices for healthcare-focused investment firms.

Stakeholder Impact

• Shareholders may experience increased volatility as the market absorbs the news of the reduced institutional position.

Next Steps

• No further filings required by this group unless ownership levels change significantly again.

Key Dates

Recommendation

The filing represents a technical change in ownership status. While it may cause short-term price fluctuations, it does not inherently change the underlying value or growth prospects of Inspire Medical Systems.

Keywords

Inspire Medical Systems, Deerfield Management, Schedule 13G, Institutional Ownership, Divestment, Common Stock